The clinical relevance of endocrine therapy-induced changes in lipid metabolism in breast cancer patients

Abstract

Commentary to:

Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients

Andrea Camerini, Marianna Rondini, Ornella Garrone, Chiara Valsuani, Sara Donati, Olimpia Siclari, Alessandro Sgambato, Gianna Tartarelli, Maura Vincenti, Valentina Polla Mattiot, Romana Prosperi Porta, Cheti Puccetti, Paolo Puccinelli, Domenico AmorosoEdit authors

This article refers to:

Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients